INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 46h ago
HOUSE PTR6h ago
SEC 13F6h ago
ROBINHOOD CHAIN6h ago
Corporate insider
WK

Ways Douglas Kirk

Director, Interim Chief Medical OfficerCIK 0001869391

EDGAR filingsOpen in network
Disclosed transactions7
Buys / sells0 / 0
Max Insider Score31
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
19
WK
Ways Douglas KirkDirector, Interim Chief Medical Officer
SPRBSPRUCE BIOSCIENCES, INC.
Option exercise
M—
1,250 sh
Dec 11, 2025Jan 21, 2026
traded Dec 11, 2025
+41dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    SPRUCE BIOSCIENCES, INC.Director, Interim Chief Medical Officer · Jan 21, 2026
19
WK
Ways Douglas KirkDirector, Interim Chief Medical Officer
SPRBSPRUCE BIOSCIENCES, INC.
Grant or award
A
—
5,000 sh
Dec 11, 2025
Jan 21, 2026
traded Dec 11, 2025
+41d
SEC FORM 4

Evidence

31
WK
Ways Douglas KirkDirector, Interim Chief Medical Officer
SPRBSPRUCE BIOSCIENCES, INC.
Option exercise
M—
1,250 sh
Dec 11, 2025Jan 21, 2026
traded Dec 11, 2025
+41dSEC FORM 4

Evidence

19
WK
Ways Douglas KirkDirector, Interim Chief Medical Officer
SPRBSPRUCE BIOSCIENCES, INC.
Grant or award
A—
266 sh
Dec 11, 2025Jan 21, 2026
traded Dec 11, 2025
+41dSEC FORM 4

Evidence

19
WK
Ways Douglas KirkDirector, Interim Chief Medical Officer
SPRBSPRUCE BIOSCIENCES, INC.
Disposition to issuer
D—
266 sh
Dec 11, 2025Jan 21, 2026
traded Dec 11, 2025
+41dSEC FORM 4

Evidence

19
WK
Ways Douglas KirkDirector, Interim Chief Medical Officer
SPRBSPRUCE BIOSCIENCES, INC.
Grant or award
A—
400 sh
Dec 11, 2025Jan 21, 2026
traded Dec 11, 2025
+41dSEC FORM 4

Evidence

19
WK
Ways Douglas KirkDirector, Interim Chief Medical Officer
SPRBSPRUCE BIOSCIENCES, INC.
Disposition to issuer
D—
400 sh
Dec 11, 2025Jan 21, 2026
traded Dec 11, 2025
+41dSEC FORM 4

Evidence